查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1388185

特种仿製药市场、份额、规模、趋势、行业分析报告：按类型、应用、最终用途、地区、细分市场预测，2023-2032 年

Specialty Generics Drugs Market Share, Size, Trends, Industry Analysis Report, By Type (Injectables, Oral Drugs, Others); By Application; By End-use; By Region; Segment Forecast, 2023- 2032
出版日期: | 出版商: Polaris Market Research | 英文 115 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris市场研究的最新研究，到2032年，全球特种仿製药市场预计将达到9,480.4亿美元。 该报告提供了对当前市场动态的详细见解，并对未来市场成长进行了分析。

许多製药、生物製药和医疗器材公司都致力于透过併购扩大市场份额。 癌症、多发性硬化症 (MS) 和爱滋病毒等危及生命的疾病的盛行率在全球范围内不断增加，预计这将推动对特殊药物的需求。 慢性病仍然是令人担忧的一个主要原因，特别是在新兴国家，慢性病是世卫组织六个区域中五个区域的主要原因。 爱滋病毒等传染病在撒哈拉以南非洲仍然普遍存在，预计将继续成为一个主要问题。 在预测期内，由于危及生命的疾病的高盛行率，特种药品市场预计将快速成长。

2020年，COVID-19大流行对医药市场产生了重大影响，导致多家公司成长放缓、销售额下降。 製造工厂面临停工，临床试验和研究不得不停止，技术工人短缺。 Market Segmentation 就是其中之一，特种仿製药业务下降了 6.6%，主要是由于大流行期间市场变化导致竞争加剧和产品结构变化。 然而，2021年，由于大规模疫苗接种、宅基地监管放宽以及治疗慢性病的专科药物需求增加，市场出现復苏迹象。

专科仿製药市场报告亮点

在预测期内，注射剂细分市场预计将成为製药业规模最大且成长最快的细分市场。 这是因为它具有持久的作用，并能很快被人体吸收，提高患者的依从性和接受度。 随着新产品批准的增加和市场的扩大，该细分市场预计将快速成长。

2022年，发炎性疾病领域占据最大的市场份额。 全世界患有类风湿性关节炎等发炎性疾病的患者数量正在增加。 根据全球 RA 网路的数据，大约有 3500 亿人患有关节炎，NHS 报告称，英国有超过 100 亿人患有关节炎。 鑑于患病率的上升，医疗保健行业的主要参与者正在增加其在该领域的市场份额。

2022年，专业药局领域占据最大的市场份额。 由于分销成本低且易于获取药品，主要仿製药製造商和保险公司通常依赖专业药房来分销其产品。

美国食品药物管理局 (FDA) 实施了监管政策来简化新产品的批准。 为了确保公众能够获得安全、有效和低成本的仿製药，该部门推出了多项举措，包括《哈奇-韦克斯曼法案》下的仿製药使用者费用修正案 (GDUFA)。 因此，知名製造商不断致力于将专门的仿製药推向市场。

目录

第一章简介

第 2 章执行摘要

第三章研究方法

第四章全球专科仿製药市场洞察

  • 特种仿製药市场 - 最终用途概况
  • 专科仿製药市场动态
    • 推动者和机会
      • 越来越重视併购，将其作为扩大特种仿製药市场份额的手段
      • 特种药物专利到期推动市场成长
    • 抑制因素和挑战
      • 这些药物的低利润率和低认知度阻碍了市场成长
  • PESTEL 分析
  • 特殊仿製药市场的最终用途趋势
  • 价值链分析
  • COVID-19 感染的影响分析

第 5 章全球特种仿製药市场（按类型）

  • 主要发现
  • 简介
  • 注射
  • 口腔医学
  • 其他

第 6 章全球特种仿製药市场（按应用）

  • 主要发现
  • 简介
  • 肿瘤
  • 发炎性疾病
  • 多发性硬化症
  • C型肝炎
  • 其他

第 7 章全球特种仿製药市场，依最终用途划分

  • 主要发现
  • 简介
  • 专业药房
  • 零售药局
  • 医院药房

第 8 章全球特种仿製药市场（按地区）

  • 主要发现
  • 简介
    • 2019-2032 年专业仿製药市场评估（按地区）
  • 特种仿製药市场 - 北美
    • 北美：2019-2032 年特种仿製药市场（按类型）
    • 北美：2019-2032 年特种仿製药市场（依最终用途）
    • 北美：特种仿製药市场，按应用划分，2019-2032 年
    • 特种仿製药市场 - 美国
    • 专业仿製药市场 - 加拿大
  • 特种仿製药市场 - 欧洲
    • 欧洲：2019-2032 年特种仿製药市场（按类型）
    • 欧洲：特种仿製药市场，依最终用途分类，2019-2032 年
    • 欧洲：特种仿製药市场，按应用划分，2019-2032 年
    • 专业仿製药市场 - 英国
    • 专业仿製药市场 - 法国
    • 专业仿製药市场 - 德国
    • 专业仿製药市场 - 义大利
    • 专业仿製药市场 - 西班牙
    • 专业仿製药市场 - 荷兰
    • 特种仿製药市场 - 俄罗斯
  • 专科仿製药市场 - 亚太地区
    • 亚太地区：2019-2032 年特种仿製药市场（按类型）
    • 亚太地区：2019-2032 年特种仿製药市场（依最终用途）
    • 亚太地区：2019-2032 年特种仿製药市场（按应用）
    • 专科仿製药市场 - 中国
    • 专业仿製药市场 - 印度
    • 专业仿製药市场 - 马来西亚
    • 专业仿製药市场 - 日本
    • 专业仿製药市场 - 印尼
    • 特种仿製药市场－韩国
  • 特种仿製药市场 - 中东和非洲
    • 中东和非洲：2019-2032 年特种仿製药市场（按类型）
    • 中东和非洲：2019-2032 年特种仿製药市场（依最终用途）
    • 中东和非洲：2019-2032 年特种仿製药市场（按应用）
    • 特种仿製药市场 - 沙乌地阿拉伯
    • 特种仿製药市场 - 阿联酋
    • 特种仿製药市场 - 以色列
    • 特种仿製药市场 - 南非
  • 特种仿製药市场 - 拉丁美洲
    • 拉丁美洲：2019-2032 年特种仿製药市场（按类型）
    • 拉丁美洲：以最终用途划分的特种仿製药市场，2019-2032 年
    • 拉丁美洲：2019-2032 年特种仿製药市场（按应用划分）
    • 专业仿製药市场 - 墨西哥
    • 特种仿製药市场 - 巴西
    • 专业仿製药市场 - 阿根廷

第九章竞争态势

  • 扩张与收购分析
    • 放大
    • 收购
  • 伙伴关係/协作/协议/揭露

第十章公司简介

  • Apotex Corp.
  • Bausch Health Companies Inc.（Valeant Pharmaceuticals International, Inc.）
  • Dr. Reddy's Laboratories Ltd.
  • Endo Pharmaceuticals Inc.
  • Fresenius Kabi Brasil Ltda
  • Hikma Pharmaceuticals PLC
  • Mallinckrodt
  • Novartis AG（Sandoz International GmbH）
  • STADA Arzneimittel AG
  • Sun Pharmaceutical Industries Ltd
  • Teva Pharmaceuticals Industries Ltd
  • Viatris Inc.
Product Code: PM1215

The global specialty generics drugs market size is expected to reach USD 948.04 billion by 2032, according to a new study by Polaris market research. The report "Specialty Generics Drugs Market Share, Size, Trends, Industry Analysis Report, By Type (Injectables, Oral Drugs, Others); By Application; By End-use; By Region; Segment Forecast, 2023- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Many pharmaceutical, biopharmaceutical, and medical device companies have been focusing on expanding their market presence by merging with or acquiring other companies. The prevalence of life-threatening diseases, such as cancer, Multiple Sclerosis (MS), and HIV, is increasing globally, which is expected to drive the demand for specialty medicines. Chronic diseases remain a major concern, particularly in emerging countries where they are the primary cause of mortality in five of the six WHO regions. Contagious diseases, such as HIV, are still widespread in Sub-Saharan Africa and are expected to continue to be a major issue. During the forecast period, the market for specialty medicines is expected to grow rapidly due to the high prevalence of life-threatening diseases.

In 2020, the COVID-19 pandemic had a significant impact on the pharmaceutical market, causing slower growth and a decline in net sales for several companies. Manufacturing plants had to face lockdown restrictions, clinical trials and studies had to be stopped, and there was a shortage of skilled labor. Mallinckrodt is one such company that experienced a -6.6% decline in its specialty generics segment, mainly due to increased competition and a change in product mix caused by market shifts during the pandemic. However, the market is showing signs of recovery in 2021, with mass vaccinations, easing of lockdown restrictions, and a growing demand for specialty medicines to treat chronic conditions.

Virtual trials offer numerous advantages, including remote data collection, increased participant engagement, and larger population inclusion. They minimize risks associated with in-person visits and reduce the burden on participants, coordinators, and investigators. By leveraging virtual methods, the clinical trials industry can overcome challenges, improve efficiency, and facilitate prompt and effective data collection.

Specialty generics drugs Market Report Highlights

During the forecast period, the Injectables segment is expected to be the largest and fastest-growing segment in the pharmaceutical industry. This is due to its ability to have long-lasting effects and quick absorption into the body, resulting in higher patient compliance and acceptance. With the increased approvals of new products and the expansion of the market, the segment is anticipated to grow rapidly.

In 2022, the largest market share was held by the segment of inflammatory conditions. The number of individuals with inflammatory conditions like rheumatoid arthritis is increasing globally. According to the Global RA Network, around 350 Billion people are living with arthritis, while the NHS has reported that over 10 Billion people in the UK are affected. In response to this rise in prevalence, major players in the healthcare industry are expanding their market share in this sector.

In 2022, the organic segment had the largest share. Organic bread improvers are made from organic ingredients and produced using organic farming methods. This means they are free from synthetic chemicals and GMOs. These organic improvers contain natural additives sourced from organic materials.

In 2022, the specialty pharmacy segment held the largest market share. Major generic manufacturers and insurance providers often rely on specialty pharmacies to distribute their products because of the low distribution costs and the easy accessibility of medicines offered by these pharmacies.

The US Food and Drug Administration (FDA) has implemented supportive regulatory policies to simplify the approval of new products. In order to make sure the public has access to safe and effective low-cost generic drugs, the agency has put several initiatives in place, including the Generic Drug User Fee Amendments (GDUFA) under the Hatch-Waxman Act. Consequently, prominent manufacturers are constantly working to introduce specialty generic drugs to the market.

The global key market players include: Apotex Corp., Bausch Health Companies Inc. (Valeant Pharmaceuticals International, Inc.), Dr. Reddy's Laboratories Ltd., Endo Pharmaceuticals Inc., Fresenius Kabi Brasil Ltda, Hikma Pharmaceuticals PLC, Mallinckrodt, Novartis AG (Sandoz International GmbH)

Polaris market research has segmented the Speciality generics drugs market report based on type, application, end-user, and region:

Specialty generics drugs, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Injectables
  • Oral Drugs
  • Others

Specialty generics drugs, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Oncology
  • Inflamatory conditions
  • Multiple sclerosis
  • Hepatitis C
  • Others

Speciality generics drugs, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)

  • Specialty pharmacy
  • Retail pharmacy
  • Hospital pharmacy

Speciality generics drugs, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Specialty Generics Drugs Market Insights

  • 4.1. Specialty Generics Drugs Market - End-Use Snapshot
  • 4.2. Specialty Generics Drugs Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing emphasizing mergers and acquisitions as a means of expanding their presence in the specialty generics market
      • 4.2.1.2. The expiration of patents on specialty drugs to drive the market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Low profitability and lack of awareness about these drugs, hinder the market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Specialty Generics Drugs Market End-Use Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Specialty Generics Drugs Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • 5.3. Injectables
    • 5.3.1. Global Specialty Generics Drugs Market, by Injectables, by Region, 2019-2032 (USD Billion)
  • 5.4. Oral Drugs
    • 5.4.1. Global Specialty Generics Drugs Market, by Oral Drugs, by Region, 2019-2032 (USD Billion)
  • 5.5. Others
    • 5.5.1. Global Specialty Generics Drugs Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Specialty Generics Drugs Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • 6.3. Oncology
    • 6.3.1. Global Specialty Generics Drugs Market, by Oncology, by Region, 2019-2032 (USD Billion)
  • 6.4. Inflamatory conditions
    • 6.4.1. Global Specialty Generics Drugs Market, by Inflamatory conditions, by Region, 2019-2032 (USD Billion)
  • 6.5. Multiple sclerosis
    • 6.5.1. Global Specialty Generics Drugs Market, by Multiple sclerosis, by Region, 2019-2032 (USD Billion)
  • 6.6. Hepatitis C
    • 6.6.1. Global Specialty Generics Drugs Market, by Hepatitis C, by Region, 2019-2032 (USD Billion)
  • 6.7. Others
    • 6.7.1. Global Specialty Generics Drugs Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Specialty Generics Drugs Market, by End-Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • 7.3. Specialty pharmacy
    • 7.3.1. Global Specialty Generics Drugs Market, by Specialty pharmacy, By Region, 2019-2032 (USD Billion)
  • 7.4. Retail pharmacy
    • 7.4.1. Global Specialty Generics Drugs Market, by Retail pharmacy, By Region, 2019-2032 (USD Billion)
  • 7.5. Hospital pharmacy
    • 7.5.1. Global Specialty Generics Drugs Market, by Hospital pharmacy, By Region, 2019-2032 (USD Billion)

8. Global Specialty Generics Drugs Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Specialty Generics Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Specialty Generics Drugs Market - North America
    • 8.3.1. North America: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
    • 8.3.3. North America: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.3.4. Specialty Generics Drugs Market - U.S.
      • 8.3.4.1. U.S.: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.3.5. Specialty Generics Drugs Market - Canada
      • 8.3.5.1. Canada: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • 8.4. Specialty Generics Drugs Market - Europe
    • 8.4.1. Europe: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.4.4. Specialty Generics Drugs Market - UK
      • 8.4.4.1. UK: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.4.5. Specialty Generics Drugs Market - France
      • 8.4.5.1. France: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.4.6. Specialty Generics Drugs Market - Germany
      • 8.4.6.1. Germany: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.4.7. Specialty Generics Drugs Market - Italy
      • 8.4.7.1. Italy: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.4.8. Specialty Generics Drugs Market - Spain
      • 8.4.8.1. Spain: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.4.9. Specialty Generics Drugs Market - Netherlands
      • 8.4.9.1. Netherlands: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.4.10. Specialty Generics Drugs Market - Russia
      • 8.4.10.1. Russia: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • 8.5. Specialty Generics Drugs Market - Asia Pacific
    • 8.5.1. Asia Pacific: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.5.4. Specialty Generics Drugs Market - China
      • 8.5.4.1. China: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.5.5. Specialty Generics Drugs Market - India
      • 8.5.5.1. India: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.5.6. Specialty Generics Drugs Market - Malaysia
      • 8.5.6.1. Malaysia: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.5.7. Specialty Generics Drugs Market - Japan
      • 8.5.7.1. Japan: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.5.8. Specialty Generics Drugs Market - Indonesia
      • 8.5.8.1. Indonesia: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.5.9. Specialty Generics Drugs Market - South Korea
      • 8.5.9.1. South Korea: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • 8.6. Specialty Generics Drugs Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.6.4. Specialty Generics Drugs Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.6.5. Specialty Generics Drugs Market - UAE
      • 8.6.5.1. UAE: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.6.6. Specialty Generics Drugs Market - Israel
      • 8.6.6.1. Israel: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.6.7. Specialty Generics Drugs Market - South Africa
      • 8.6.7.1. South Africa: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • 8.7. Specialty Generics Drugs Market - Latin America
    • 8.7.1. Latin America: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.7.4. Specialty Generics Drugs Market - Mexico
      • 8.7.4.1. Mexico: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.7.5. Specialty Generics Drugs Market - Brazil
      • 8.7.5.1. Brazil: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.7.6. Specialty Generics Drugs Market - Argentina
      • 8.7.6.1. Argentina: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Apotex Corp.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Bausch Health Companies Inc. (Valeant Pharmaceuticals International, Inc.)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Dr. Reddy's Laboratories Ltd.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Endo Pharmaceuticals Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Fresenius Kabi Brasil Ltda
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Hikma Pharmaceuticals PLC
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Mallinckrodt
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Novartis AG (Sandoz International GmbH)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. STADA Arzneimittel AG
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10.Sun Pharmaceutical Industries Ltd
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Teva Pharmaceuticals Industries Ltd
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Viatris Inc.
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development

List of Tables

  • Table 1 Global Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 2 Global Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 3 Global Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 4 Specialty Generics Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 6 North America: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 7 North America: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 8 U.S.: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 10 U.S.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 11 Canada: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 12 Canada: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 13 Canada: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 14 Europe: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 15 Europe: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 16 Europe: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 17 UK: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 18 UK: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 19 UK: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 20 France: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 21 France: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 22 France: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 23 Germany: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 25 Germany: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 26 Italy: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 27 Italy: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 28 Italy: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 29 Spain: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 30 Spain: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 31 Spain: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 35 Russia: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 36 Russia: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 37 Russia: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 41 China: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 42 China: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 43 China: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 44 India: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 45 India: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 46 India: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 50 Japan: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 51 Japan: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 52 Japan: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 56 South Korea: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 58 South Korea: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 65 UAE: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 66 UAE: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 67 UAE: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 68 Israel: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 69 Israel: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 70 Israel: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 71 South Africa: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 73 South Africa: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 74 Latin America: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 76 Latin America: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 77 Mexico: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 79 Mexico: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 80 Brazil: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 82 Brazil: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 83 Argentina: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 85 Argentina: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Specialty Generics Drugs Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Specialty Generics Drugs Market, by Application, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Type
  • Figure 9. Global Specialty Generics Drugs Market, by Type, 2022 & 2032 (USD Billion)
  • Figure 10. Market by End-Use
  • Figure 11. Global Specialty Generics Drugs Market, by End-Use, 2022 & 2032 (USD Billion)
  • Figure 12. Specialty Generics Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Specialty Generics Drugs Market